ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI -Driven Platform LENSai ...
Immunogenicity Screening: The platform identifies immunogenic hotspots and predicts potential adverse immune responses, reducing the risk of anti-drug ...
Read the original at FirstWord Pharma ↗
- Topics
- AI Safety & Existential Risk
- Tracked via
- “AI Risks”